|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/52 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61K 31/167 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/404 | (2006.01) |
| (11) | Patento numeris | 3426254 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17762648.8 |
| Europos patento paraiškos padavimo data | 2017-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2017/050301 |
| Data | 2017-03-09 |
| (87) | Numeris | WO 2017/154001 |
| Data | 2017-09-14 |
| (30) | Numeris | Data | Šalis |
| 201662306147 P | 2016-03-10 | US |
| (72) |
SHELACH, Noa , IL
|
| (73) |
Lutris Pharma Ltd. ,
27 Habarzel St., 6971039 Tel Aviv,
IL
|
| (54) | USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS |
| USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS |